TEAM

• Medical Director, Orchids Breast Health, Pune
• Managing Trustee, Prashanti Cancer Care Mission, Pune
• Director, Oncosciences Jehangir Hospital, Pune
• Regional Convenor of M.Ch Breast Oncoplasty Program University of East Anglia, UK

Dr. Koppiker is an internationally renowned Breast Oncosurgeon and the Medical Director of Orchids Breast Health Center, Pune which is a one-of-its kind Integrated Center of Affordable Excellence for Breast Cancer. He is also the Founder Director of International School of Oncoplastic Surgery- a joint initiative with the Breast Oncoplasty Training Program, University of East Anglia, UK. He is Asia Convenorof M.Ch. (Breast Oncoplasty) Program of UEA and a faculty at the School of Oncoplastic Surgery , USA.

Outside of Tata Memorial Hospital, Mumbai, DrKoppiker was the first Oncosurgeon in Pune to lead the establishment of the 1st integrated cancer center namely the Budhrani Cancer Institute, Pune and Inlaks and Budhrani Hospital, Pune, He then helped set up 2 more reputed cancer centers first as the Director of the Ruby Hall Clinic Cancer Center and then at Cancer Clinic and Research Center at Jehangir Hospital, Pune. Dr. Koppiker has been an International Investigator in several important Breast Cancer clinical trials and leading a translational research group with active collaborations with premier national and international research institutes.

Dr. Koppiker is also the Founding Director and Managing Trustee of Prashanti Cancer Care Mission, -a non-profit NGO working in Pune active in cancer education, training and research in addition to providing free or affordable cancer treatment and rehabilitation to underprivileged cancer patients.

Dr. Jerome Periera and Dr. CB Koppiker have been collaborating to develop Breast Oncoplasty Training Programs in Asia since 2017. Starting with organizing hands-on workshops, symposia and conferences, this collaboration has evolved into formal establishment of a 3-year M.Ch. Degree Program jointly organized by Prashanti Cancer Care Mission and University of East Anglia, UK in 2017. Prashanti Cancer Care Mission has formed a highly successful partnership with UEA to establish this programme in Asia and has already recruited over 65 surgeons from India, Bangladesh, Sri lanka, Maldives, Indonesia, Malaysia etc.

• President-Asian Society of Mastology(ASOMA)
• President & Governor American College of Surgeons-India ChapterHead-Surgery-VMMC Safdarjang Hospital, New Delhi

• Senior Lecturer, Kings College, London
• Clinical Lead & Chair of Breast Tumour Group. GSTT
• Chair – Breast, South East London Accountable Cancer Network
• Education Training Committee – ESSO
• Clinical Trainer – M.Ch. in Oncoplastic Breast Surgery
• Examiner – UEMS

Ashutosh is currently working as an Onco-plastic and reconstructive breast surgeon at Guy’s & St. Thomas’ NHS Foundation Trust and Guy’s Cancer, London. He is the Chair of Breast Cancer Multidisciplinary Team and leads the Breast Tumour Working Group. He also Chairs the Breast Stream of the South-East London Accountable Cancer Network, comprising of several hospitals across the south-east of London. He specialises in onco-aesthetic breast conservation surgery and partial as well as whole breast reconstruction. He has a special interest in hereditary breast cancer and breast cancer in young women.
He is a Hon. Senior Lecturer at the Faculty of Life Sciences & Medicine, Kings College, London. He is an enthusiastic academic and teaches a range of students from undergraduate is a clinical tutor for the super-speciality M.Ch. In onco-plastic breast surgery courses run internationally. He also sits on the board of the Education & Training Committee of the European Society of Surgical Oncology. He is an executive committee member of the Indian Association of Surgical Oncology, the Breast Reconstructive & Aesthetic Surgeons Association as well as the Asian Society of Mastology. He serves as an examiner for the EBSQ, European Board Certification examination in Breast surgery. Ashutosh, is regularly invited as a speaker to several key International Breast Cancer Conferences, masterclasses, surgical workshops, webinars and training courses.

He maintains an extensive research portfolio and amongst a host of other trials, is the principal investigator on two unique first in man research trails involving novel intra-operative imaging techniques He was also the co-investigator on the first ever prospective trial on the use of biologics in breast reconstruction. He serves as an advisor to companies involved in the manufacture of aesthetic surgical devices. He is extremely well published and has written several chapters in essential textbooks on breast cancer surgery. He serves on the editorial board of two international journals.

Consultant Oncoplastic Breast Surgeon at James Paget University Hospitals NHS Foundation Trust and Professor of Surgery and Programme Director for Specialist Mastership Programmes in Surgery at the University of East Anglia, Norwich. Lead for Training, Mentorship and Quality Assurance of Programs at BreastGlobal

Maurizio Nava achieved his Bachelor of Medicine and Surgery at the University of Milan in 1977. He majored in oncology in 1980 and general surgery in 1986. In 1993, he then majored in plastic and reconstructive surgery. Since graduating he worked at the Istituto Nazionale dei Tumori in Milan and from 1997 till 2014 as Director of the Plasic Surgery Unit. As Adjunct Professor – School of Specialization in Plastic Surgery, University of Milan and from 2016 University of Genova, he participates in national and international studies on implants, ADMs, fat cells and microsurgical flaps in oncoplastic breast surgery and breast aesthetic surgery. He is President of the Oncological Reconstructive School a NOT for PROFIT, that is proposing updates to the international multidisciplinary field of oncoplastic reconstructive and aesthetic breast surgery, and an exchange of ideas with patients.

He is author and co-author of more than 200 publications in Italian, English and Spanish on oncological surgery, reconstructive and aesthetic surgery of the breast. He is author of five books on ocncoplastic, reconstructive and aesthetic surgery of the breast and author of many chapters in other books. He has organized several international conferences concerning both reconstructive and aesthetic surgery of the breast. He and his team are dedicated to the surgery of the breast from tumour to reconstruction and to the aesthetic outcome and body contouring. He introduced new surgical techniques both in mastectomy and reconstruction and aesthetic breast surgery. MAURIZIO BRUNO NAVA MD GRETA ONCOPLASTIC MILANO NAPOLI CATANIA

Dr. Nicola Rocco is a breast surgical oncologist and assistant professor at the University of Naples Federico II (Naples, Italy) since January 2022.
He previously worked as Chief of the Breast Surgical Unit of the Malzoni Cancer Center – MACC (Avellino, Italy).

He obtained his Medical Degree at University Federico II of Naples in 2005 and the Specialization in General Surgery at the same University in 2012.

He obtained a PhD in Advanced Biomedical and Surgical Therapies at the University of Naples in cooperation with the National Research Council, studying the potential applications of 3D-printing and regenerative medicine in the field of breast reconstruction.

Dr. Zoltán Mátrai is a distinguished oncoplastic breast surgeon and Senior Consultant at Hamad Medical Corporation, Doha, Qatar. He holds multiple advanced qualifications (MD, PhD, habil., FEBS in Surgical Oncology and Breast Surgery) and has held key leadership roles, including heading the Department of Breast and Soft Tissue Surgery and the Centre of Surgical Oncology at the National Institute of Oncology, Hungary.

He is the founder of the Central and Eastern European Breast Cancer Surgical Consortium and a past president of the Hungarian Society of Oncology. With over 160 scientific publications and several book chapters, he is also the editor of Principles and Practice of Oncoplastic Breast Surgery.

Actively involved in global oncology initiatives, he serves on international boards including BRESO, OPBC, and EUBREAST. His clinical and research work focuses on oncoplastic breast surgery and optimizing axillary treatment, with a strong emphasis on improving patient outcomes and quality of life.

Prof. Bahadir M. Gulluoglu works at Marmara University School of Medicine, Department of General Surgery since 1991 and currently is a full-time professor (tenured) at the same institution since 2009. He formerly served as the Vice-Coordinator and Head-Coordinator for clinical graduate medical education at Marmara University (2006-2012). Prof. Gulluoglu is also a member of Institutional Review Board at his university since 2011. He also serves at University of Medicine, Pharmacy, Science and Technology of Targu Mures, Romania as faculty member for doctorate studies. Prof. Gulluoglu is the co-founder of Marmara University Hospital, Breast Center (2001) which is a member of Breast Centres Network. Prof. Gulluoglu also works as the core faculty member at European Academy of Senology (EAoS), International Breast Ultrasonography School (IBUS), European School of Oncology (ESO), Norwegian Breast & Endocrine Surgery Board and MANOSMED Mediterranean University of Mastology. He is also the deputy secretary of UEMS European Board of Surgery, Division of Breast Surgery and holds honorary fellowships of both European Board of General Surgery and Breast Surgery. Prof. Gulluoglu currently serves at BRESO (European Breast Surgical Oncology Certification) Structure Working Group as theoretical knowledge committee member. Prof. Gulluoglu is currently the president of SENATURK (Senology Academy-Turkey), executive committee member of Breast Surgery International (BSI) and country coordinator of Oncoplastic Breast Consortium (OPBC) in Basel, Switzerland. He formerly served at Senologic International Society (SIS) as deputy secretary and Committee for National Breast Cancer Screening at Turkish Ministry of Health as chairman. Besides, Prof. Gulluoglu is an honorary member of both Bulgarian Surgical Society and Romanian Society for Breast Surgery and Oncology. He is the founding executive member of Turkish Society of Breast Surgery. Prof. Gulluoglu is the institutional research coordinator of EORTC Breast Cancer Group and member of ASCO Resource-Stratified Guideline Advisory Group in Alexandria, USA. Prof. Gulluoglu is the co-chair of International Istanbul Breast Cancer Conference (Breastanbul) and (Turkish) National Health Quality Forum. He is the convenor of Istanbul Reconstructive Breast Cancer Surgery (IREBS) Workshops and currently serves as the associate editor at Breast Care (Karger).

Giuseppe Catanuto is a consultant breast surgeon in Catania where he was appointed in 2012. He worked at the Royal Marsden Hospital- Sutton (UK) as a fellow of Mr. Guidubaldo Querci della Rovere (2003-2004) and in Milan at Istituto Nazionale dei Tumori (2004-2006) during his PhD. In 2006 he became a consultant oncoplastic breast surgeon at Humanitas-Catania where he developed a specific expertise in therapeutic mammaplasties and conservative mastectomies. During the last twelve years he served as a consultant of the “Scuola di Oncologia Chirurgica Ricostruttiva”. On behalf of this organization he coordinated the International Fellowship “G. Querci della Rovere”.

In 2012. His research areas are: oncoplastic surgery including the development of a questionnaire on post breast reconstruction quality of life on behalf of the EORTC Quality of Life Group, decision making in breast surgery and mathematical modeling of breast shape. He is also a professor at the master in oncoplastic surgery and integrated treatments at the University of Genova and honorary consultant of the department of mathematics and informatics at the University of Catania

Specialization in Mastology in Brazil, and fellowships programs in Breast Surgery and in Reconstructive Surgery in Italy, England, and Germany. He works as a breast oncoplastic surgeon at the Federal University of Goias and at the Araujo Jorge Hospital in Goiania (Brazil). Reviewer for many journals, author and co-author of dozens of scientific papers and book chapters. Authored of a textbook on Oncoplasty and Breast reconstruction in Brazil. Experienced faculty in Oncoplastic and breast Reconstruction in Brazil and abroad. Head of a traditional hands-on course on Oncoplastic Surgery, organized by the Brazilian Society of Mastology in Goiania (Brazil).

Dr. Shalaka Joshi is a Professor and Surgical Oncologist at Tata Memorial Centre and Homi Bhabha National University, Mumbai, associated with the Clinician Scientist Laboratory at ACTREC. She holds an MS, M.Ch in Surgical Oncology, and an MRes in Translational Cancer Medicine, with fellowship training from King’s College London.

Her clinical expertise lies in breast and oncoplastic breast surgery, managing both benign and malignant conditions. She has contributed extensively to research, with multiple publications and presentations at national and international conferences.

Shaheenah Dawood is a Consultant medical oncologist and associate professor in clinical oncology in the United Arab Emirates. She trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training she was awarded multiple scholar in training awards and ASCO merit awards. She has served as an editorial fellow at the New England Journal of medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles and 12 book chapters. She serves as a reviewer for multiple journals including the Journal of Clinical Oncology. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the UAE Cancer Congress that is held annually in Dubai and is co-president of the Asia pacific breast cancer summit (ABCS) and Asia pacific gastrointestinal cancer summit (APGCS). She has also recently launched the international BRCA forum and MENA immune-oncology summit.

Isabel T. Rubio is the Head of Breast Surgical Oncology at Clinica Universidad de Navarra and Professor of Surgery at the University of Navarra in Madrid, Spain. She studied medicine at the Faculty of Medicine in Salamanca, Spain, and become a Board certified General Surgeon. She had additional training for two year as a Breast Surgical Oncology Fellow at The University of Arkansas for Medical Sciences and the Arkansas Cancer Center at Little Rock, USA and for one year at the MD Anderson Cancer Center in Houston, Texas, USA. She completed her PhD in 2000 on “Sentinel lymph node biopsy in breast cancer ”. She has been Chief of Breast Surgical Oncology at Hospital Universitario Vall d´Hebron and Associate Professor of Surgery at Universitat Autónoma de Barcelona, Spain. (2009-2018). She is the director of the Breast Surgery Fellowship program at her Institution.

Dr. Rubio is active in many societies, as EUSOMA president (European Society of Breast Cancer Specialists), President-elect of the European Society of Surgical Oncology (ESSO), member of the Executive Committee at the European Cancer Organization, founding member and past President of the Spanish Association of Breast Surgeons (AECIMA), Board member of EUBREAST, and member of the SSO and the American Society of Breast Surgeons.

She is associate editor in Breast of the Journal of Surgical Oncology, and reviewer for The Breast, the European Journal of Surgical Oncology and the Annals of Surgical Oncology. She obtained the European Board of Surgery Qualification in Breast Surgery and since 2015 is officer at the UEMS Breast Surgery Division and participates as an examiner in the EBSQ Examinations in Breast Surgery.

Dr. Rubio is involved in many randomized trials and part of the Executive committee in many of them. (MINDACT, Eribulin-SOLTI100, EORTC 10085). She has received grants to develop her research by the Susan G. Komen Foundation, Spanish Ministry of Health and other institutions. Dr. Rubio has published over 100 peer review manuscripts and many book chapters.

Her interest is in sentinel lymph node biopsy, neoadjuvant treatments, surgical management of BRCA mutation carriers, and the role of prognostic markers (genomic profiles, liquid biopsy). Also her interest is focused on the standardization of Breast surgical training and Breast units.

Dr. Sneha Joshi is a senior scientist at CTCR-PCCM. She received her M.S from the University of Pune and obtained her Ph.D in Immunology from Rutgers University, NJ, USA. She completed her post-doctoral training at Columbia University, NY, USA in Osteoimmunology with a focus on Leukaemia blasts.

Dr. Rupa is currently working with CTCR as a Consultant Scientist. She did her PhD in Cancer Biology from ACTREC-TMC in Mumbai and a four-year postdoctoral fellowship at IISER Pune. She has also been working on the Indian Cancer Genome Atlas (ICGA) and has been a part of the team to work on Ethics Committee approvals for ICGA.